FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
Guggenheim maintained a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and cut the price target to $26.00 (from $34.00), following the company's 3Q earnings report. PAHC reported F'3Q16 EPS of $0.38, $0.03 lower than consensus. PAHC lowered its F'16 revenue and EPS guidance to $745MM-$750MM, and... More

